Who We Are


The Regulatory Guidance for Academic Research of Drugs and Devices (ReGARDD) affiliates are comprised of regulatory affairs specialists and experts from North Carolina Institutions that receive funding from the NIH Clinical and Translational Science Awards (CTSA) Program. Currently these institutions are the University of North Carolina at Chapel Hill, Duke University, Wake Forest School of Medicine, and RTI International.

Combining the regulatory talents from the North Carolina CTSAs and the research triangle park (RTP) area enables sharing of ideas, lessons learned, historical information, and the development of successful strategies to assist the academic researcher in navigating an increasingly complex regulatory environment. To learn more about each of the affiliates involved in ReGARDD, click on the institution's logo below:

The ReGARDD program is funded in part by Clinical and Translational Science Awards (CTSA) Program from the National Center for Advancing Translational Sciences, National Institutes of Health, to each of the member institutions:

  • University of North Carolina at Chapel Hill and RTI International (grant UL1TR001111)
  • Duke University (grant UL1TR001117)
  • Wake Forest University (grant UL1TR001420).

The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.